NextGen Customer Engagement Platform: Empowering Digital Transformation in the Pharmaceutical Industry
On November 6th, AstraZeneca, Tencent Health, and Accenture jointly announced the launch of the NextGen Customer Engagement Platform at the 6th China International Import Expo. This collaboration aims to assist AstraZeneca China in creating a future-oriented GoToMarket business model, integrating customer management and engagement through an innovative platform ecosystem.
AstraZeneca, a globally renowned biopharmaceutical company driven by innovation, has been operating in the Chinese market for 30 years. In this new phase of development, AstraZeneca prioritizes patient-centric approaches and leverages technology to explore the possibilities of digital healthcare. Together with its partners, the company aims to enhance integrated diagnosis and treatment solutions, enable comprehensive care management, and introduce fresh perspectives to chronic disease management, primary healthcare, and multi-scenario medical services.
The NextGen Customer Engagement Platform:
The NextGen Customer Engagement Platform emerges in this context. This collaboration revolves around three core concepts: an integrated user experience centered around healthcare professionals (HCPs), data-driven business decision-making, and the establishment of a platform ecosystem. The platform aims to support digital healthcare development comprehensively, encompassing communication efficiency, cross-department collaboration, data insights, and intelligent decision-making.
Tencent's Contribution:
Leveraging its leading expertise in artificial intelligence, big data, and cloud computing, Tencent is committed to enhancing efficient communication and collaboration between medical enterprises and healthcare professionals. Tencent Health's Next Generation Engagement Solution (NGES), built on Tencent Cloud's infrastructure, cloud-native architecture, and digital security capabilities, seamlessly integrates IaaS, PaaS, and SaaS layers. The solution incorporates CRM, Events, and MCM tools, providing a cloud-based end-to-end solution for pharmaceutical marketing. With innovation as its driving force, Tencent Health aims to facilitate the healthy and sustainable development of the pharmaceutical industry.
Future Prospects:
Looking ahead, Tencent Health plans to provide comprehensive solutions across the value chain of pharmaceutical enterprises. Through powerful technological advancements and product ecosystems, the company will optimize the allocation and utilization of medical resources. By embracing an open and forward-thinking approach, Tencent Health aims to support the digital transformation of enterprises through continuous exploration and research and development.
The collaboration between AstraZeneca, Tencent Health, and Accenture marks a significant milestone in the digital transformation of the pharmaceutical industry. The NextGen Customer Engagement Platform brings together cutting-edge technologies, data-driven insights, and an innovative ecosystem, empowering AstraZeneca China to create a future-oriented business model and revolutionize customer management and engagement. With Tencent Health's expertise and solutions, the pharmaceutical industry is poised to achieve high-quality and sustainable development in the era of digitalization.
Looking for chemical products? Let suppliers reach out to you!
2026-07-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Tencent Tang Daosheng: Accelerate the embrace of digital health and activate the endogenous power of the industry
-
Tencent's AI drug discovery platform breaks through the closed-loop capability of high-throughput dry and wet experiments
-
Tencent Cloud officially released two new solutions of intelligent manufacturing
-
End of an Era: KDC/One to Close 150-Year-Old Somerset Cosmetics Factory as Production Shifts to Scotland
-
Bridgestone Sells Mexican Carbon Black Plant to Cabot for $70 Million Global Supply Chain Strategy Takes Major Step
-
China Shenhua Plans Major Asset Injection with 13 Companies Involved Stock Trading Halted for Up to 10 Days
-
US and Pakistan Announce Energy Deal Targeting 9.1 Billion Barrels Oil Potential $11.3 Billion Import Bill Prompts Urgent Action
-
Luoyang Refining’s 2.78 Billion USD Ethylene Project Achieves Full Start-Up Annual Revenue to Hit 1.69 Billion USD
-
India Swings the Tariff Axe at Made-in-China: Epoxy Resins Are Just the Beginning—The Road for Chinese Chemicals Abroad Is No Longer Smooth
-
Huntsman Q2 Net Loss Hits $158 Million Revenue Down 7 Percent Cost-Cutting Ramps Up as Demand Slumps
Recommend Reading
-
Trump Hits Brazilian Beef with 50 Percent Tariff Experts Warn of Price Shifts and Global Trade Shakeup
-
Colombia Issues Emergency Alert on Illegal Meat Sales Invima Warns of Severe Health Risks
-
Brazil Raises Tomato Difenoconazole Limit 90-Fold New Pesticide Residue Standards for Key Crops Take Effect
-
Korea MFDS Proposes Major Edits to Imported Food Hygiene Rules Deadline for Public Comments Set for August 20
-
Vertex Shares Plunge 14.4 Percent After Pain Drug Trial Misses Key Target and Study Halt
-
Premium Global Chemical Sourcing Requests (12 - 16 Jan, 2026)
-
Weakening Fundamentals Lead to Declining Prices for Polyester Staple Fiber
-
Supply and Demand Expectations Gradually Weakening, PTA Prices Tend to Remain Weak
-
Lithium carbonate enters a tight balance phase, with prices steadily rising
-
Supply and Demand Improve; Early Month Sees Rising Prices for n-Butanol Market